Biological validation of TIE1 and CaMKIIβ expression in an independent clinical cohort across distinct muscle groups, along with supportive network analysis, provides weight to the claim that these are useful markers of cancer cachexia in humans. This evidence concerns the gene TIE1 and cancer.